Adherence to Chronic Positive Airway Pressure Therapy in Obese Patients With Sleep-disordered Breathing

To describe the adherence to positive airway pressure therapy among obese adult patients refered to the respiratory center east

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sleep Disorder; Breathing-Related Adherence, Treatment Behavior Body Weight Health Behavior Mental Disorders Nervous System Diseases Neurologic Manifestations Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms Sleep Wake Disorders Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Respiratory Center East, Rigshospitalet

Glostrup Municipality, 2600, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 years or older
Body mass index above 30 kg/m2
Referred to the Respiratory Center East between january 2021 and january 2024

Exclusion criteria

Neuromuscular disease
Spinal cord injury
Craniofacial malformation
Scoliosis
Diaphragmatic paresis
Referred to profylactic secrete management only
Already in treatment with nPAP with use of nPAP a minimum of 4 hours per night for 70% of the time within a consecutive 30-day period during the last 90 days.
No medical indication for start of nPAP.

Treatment and study plan

Positive airway pressure therapy

Device

Use of Positive Airway Pressure Therapy

Primary outcomes

Compliance to noninvasive positive airway pressure therapy (nPAP) - 90 days

Time frame: 0-3 months after start of noninvasive positive airway pressure therapy

Use of nPAP a minimum of 4 hours per night for 70% of the time within a consecutive 30-day period within the first 90 days of having the equipment.

Secondary outcomes

Mortality

Time frame: 1 year

Mortality up to 1 year after initiation of noninvasive positive airway pressure therapy
Compliance to noninvasive positive airway pressure therapy (nPAP) - 1 year

Time frame: Time Frame: 275 to 365 day after start of noninvasive positive airway pressure therapy

Use of nPAP a minimum of 4 hours per night for 70% of the time within a consecutive 30-day period within the 275 to 365 day of having the equipment.

Sponsors and collaborators

Lead sponsor

Anne Kathrine Staehr-Rye

Other

Registry information

Important dates

Study start: 2021
Primary completion: 2025
Study completion: 2026
First posted: Jan 23, 2026
Registry last updated: Jan 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed